Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - DUSA PHARMACEUTICALS INC | y83067e10vk.htm |
| EX-99.1 - EX-99.1 - DUSA PHARMACEUTICALS INC | y83067exv99w1.htm |
| EX-31.B - EX-31.B - DUSA PHARMACEUTICALS INC | y83067exv31wb.htm |
| EX-21.A - EX-21.A - DUSA PHARMACEUTICALS INC | y83067exv21wa.htm |
| EX-32.A - EX-32.A - DUSA PHARMACEUTICALS INC | y83067exv32wa.htm |
| EX-32.B - EX-32.B - DUSA PHARMACEUTICALS INC | y83067exv32wb.htm |
| EX-31.A - EX-31.A - DUSA PHARMACEUTICALS INC | y83067exv31wa.htm |
EXHIBIT 23(a)
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-150965,
333-147614, 333-134814, 333-73039, 333-84071, 333-31676, 333-33118, and 333-113913 on Form S-3
and Registration Statements Nos. 333-155431, 333-141615, 333-126345, 333-92259, and 333-57890
on Form S-8 of our report dated March 4, 2010, relating to the consolidated financial
statements of DUSA Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of DUSA
Pharmaceuticals, Inc. for the year ended December 31, 2009.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 4, 2010
March 4, 2010